← Leaderboards
Azra Raza
Rush University Medical Center
$4,021,821
Attributed
$4,021,821
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $243.7K · FY2005–10$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,509,913 · 9
By mechanism
P01$5,095,374 · 4
P20$1,015,189 · 4
R21$399,350 · 1
Top collaborators
No co-investigators on record.
Most similar at Rush University Medical Center
Same institution · by research overlap
- Cheryl B Knudson$3,864,180
- Sally Arai$655,043
- Harvey D Preisler$1,738,188
- Carol A Westbrook$1,484,240
Others in their field
Top investigators on “Blood /Lymphatic Neoplasm”
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$22,155,424
- Robert S Negrin · Stanford University$14,536,518
- Rakesh K. Jain · Massachusetts General Hospital$10,055,176
- Michael J O'Connell · Mayo Clinic Coll Of Medicine, Rochester$5,625,046
- Philip J Stella · Saint Joseph Mercy Health System$4,435,950
- Henry T Lynch · Creighton University$3,479,877
Research focus
Blood /Lymphatic NeoplasmBiomedical FacilityClinical ResearchHuman SubjectPreneoplastic StateMetabolomicsHuman Therapy EvaluationMicroscopyHematopoiesisGrantAntibacterial AgentsHematopoietic Stem CellsApoptosisDexamethasoneCombination ChemotherapyGenesCostCytokineClinical Trial Phase ICell Bank /RegistryCell Growth RegulationCell Population StudyCell ProliferationHematopoietic Tissue
Grant awards (18)
Prediction of Response to Revlimid$161,000
R21 · FY2010 · HL · contact PI
Prediction of Response to Revlimid$238,350
R21 · FY2009 · HL · contact PI
COBRE: U NEL: CORE A: METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, CYTOMETRY$243,653
P20 · FY2008 · RR · contact PI
COBRE: U NEL: CORE A: METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, CYTOMETRY$171,619
P20 · FY2007 · RR · contact PI
COBRE: U NEL: CORE A: METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, CYTOMETRY$157,748
P20 · FY2006 · RR · contact PI
COBRE: U NEL: CORE A: METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, CYTOMETRY$217,196
P20 · FY2005 · RR
CORE-- METABOLOMICS: PROTEOMICS, MICROSCOPY, GENOMICS, C$224,973
P20 · FY2004 · RR
SECONDARY HEMATOLOGIC DISORDERS--GENESIS AND TREATMENT$429,000
P01 · FY2002 · CA
CORE--CLINICAL$312,755
P01 · FY2002 · CA
CLINICAL AND BIOLOGICAL STUDIES IN MYELODYSPLATIC SYNDROMES$312,755
P01 · FY2002 · CA
CORE--CELL PROCUREMENT$312,755
P01 · FY2002 · CA
SECONDARY HEMATOLOGIC DISORDERS--GENESIS AND TREATMENT$2,059,092
P01 · FY2001 · CA
CORE--CELL PROCUREMENT$312,755
P01 · FY2001 · CA
CORE--CLINICAL$312,755
P01 · FY2001 · CA
CLINICAL AND BIOLOGICAL STUDIES IN MYELODYSPLATIC SYNDROMES$312,755
P01 · FY2001 · CA
CLINICAL AND BIOLOGICAL STUDIES IN MYELODYSPLATIC SYNDROMES$243,584
P01 · FY2000 · CA
CORE--CELL PROCUREMENT$243,584
P01 · FY2000 · CA
CORE--CLINICAL$243,584
P01 · FY2000 · CA